0001209191-22-037514.txt : 20220616 0001209191-22-037514.hdr.sgml : 20220616 20220616170858 ACCESSION NUMBER: 0001209191-22-037514 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: William Arsani CENTRAL INDEX KEY: 0001848372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40288 FILM NUMBER: 221021418 MAIL ADDRESS: STREET 1: C/O DESIGN THERAPEUTICS, INC. STREET 2: 6005 HIDDEN VALLEY ROAD, SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Design Therapeutics, Inc. CENTRAL INDEX KEY: 0001807120 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 823929248 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 BUSINESS PHONE: 858-293-4900 MAIL ADDRESS: STREET 1: 6005 HIDDEN VALLEY ROAD STREET 2: SUITE 110 CITY: CARLSBAD STATE: CA ZIP: 92011 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-06-15 0 0001807120 Design Therapeutics, Inc. DSGN 0001848372 William Arsani C/O DESIGN THERAPEUTICS, INC. 6005 HIDDEN VALLEY ROAD, SUITE 110 CARLSBAD CA 92011 1 0 0 0 Stock Option (right to buy) 13.69 2022-06-15 4 A 0 15000 0.00 A 2032-06-14 Common Stock 15000 15000 D The shares subject to the option vest in equal monthly installments over 12 months following June 15, 2022 provided that the shares subject to the option will in any case be fully vested on the date of the Company's next annual meeting of stockholders. /s/ Mustapha Parekh, Attorney-in-Fact 2022-06-16